Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.
Pfizer (PFE: NYSE) By MKM Partners ($29.30, May 23, 2013) We are increasing our fair-value estimate of Neutral-rated Pfizer to $29 from $28 on an earlier-than-expected Zoetis spinoff. Pfizer (ticker: PFE) expects to split off its remaining
...Apologies for having fewer posts than usual today. I’m really tired and have been having trouble concentrating. No particular trigger, just seems to be a weirdly low energy day.
Cheese maker warned against supplying Gloucester cheese rolling BBC (Richard Smith)
How the Ring Nebula became a doughnut: Stunning new Hubble images find...